US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 01:35:53 Source：Worldly Weaves news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
- Queen Camilla reveals she's seen the first season of Bridgerton
- Folk Song Enthusiast Keeps Daur Heritage Alive
- University Graduate Develops Cooperative, Helps Farmers Attain Wealth
- Across China: Ethnic Bai Woman Travels Far to Promote Cultural Heritage
- Kylie Jenner displays her VERY edgy fashion sense in cleavage
- Pic Story of Flower
- Pursuing Dream in Vast Fields
- The IRS is quicker to answer the phone on this Tax Day
- Trump or Biden? Either way, US seems poised to preserve heavy tariffs on imports
- Seedling Breeder Helps Farmers Attain Wealth by Developing Vegetable Cooperative
- Kid Rock 'uses N
- Inheritor Creates Ceramic Work to Celebrate Upcoming Asian Games
- Xinjiang Story: Uygur Dancer Blends Folk Elegance with Modern Street Beats
- Women Hold up 'Half the Sky' in China's Scientific Research
- NBA playoffs: Edwards leads Wolves to 98
- Profile: Wheelchair
- Spring Bud Blooms
- Pic Story of Post
- Xander Schauffele gets validation and records with one memorable putt at PGA Championship
- Interview: Hangzhou Asian Games one of the best events: Kuwaiti gold medalist
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Worldly Weaves news portal sitemap